Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins

Hepatology

Volumn 28, Issue 1, 1998, Pages 192-201

  Moradpour, Darius ^a   Kary, Petra ^a   Rice, Charles M ^b   Blum, Hubert E ^a,c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS ANTIGEN; STRUCTURAL PROTEIN; TETRACYCLINE; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION; HALF LIFE TIME; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; NORTHERN BLOTTING; OPEN READING FRAME; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSGENE;

CELL DIVISION; CELL LINE; CELL SURVIVAL; CHROMOSOME MAPPING; GENE EXPRESSION REGULATION; GENES, VIRAL; HEPACIVIRUS; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SUBCELLULAR FRACTIONS; TRANSCRIPTION, GENETIC; TRANSGENES; VIRAL NONSTRUCTURAL PROTEINS; VIRAL STRUCTURAL PROTEINS;

EID: 0031862855     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280125     Document Type: Article

References (31)

1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-362.
2. Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-364.
3. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. HEPATOLOGY 1990;12:671-675.
4. Major ME, Feinstone SM. The molecular virology of hepatitis C. HEPATOLOGY 1997;25:1527-1538.
5. Shimotohno K, Tanji Y, Hirowatari Y, Komoda Y, Kato N, Hijikata M. Processing of the hepatitis C virus precursor protein. J Hepatol 1995;22 (suppl. 1):87-92.
6. Lohmann V, Koch JO, Bartenschlager R. Processing pathways of the hepatitis C virus proteins. J Hepatol 1996;24 (suppl. 2):11-19.
7. von Weizsācker F, Wieland S, Kōck J, Offensperger W-B, Offensperger S, Moradpour D, Blum HE. Gene therapy for chronic viral hepatitis: ribozymes, antisense òligonucleotides, and dominant negative mutants. HEPATOLOGY 1997;26:251-255.
8. Kim JL, Morgenstern KA, Lin C, Fox T, Dwyer MD, Landro JA, Chambers SP, et al. Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell 1996;87:343-355.
9. Love RA, Parge HE, Wickersham JA, Hostomsky Z, Habuka N, Moomaw EW, Adachi T, et al. The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell 1996;87:331-342.
10. Lanford RE, Sureau C, Jacob JR, White R, Fuerst TR. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology 1994;202:606-614.
11. Ito T, Mukaigawa J, Zuo J, Hirabayashi Y, Mitamura K, Yasui K. Cultivation of hepatitis C virus in primary hepatocyte culture from patients with chronic hepatitis C results in release of high titre infectious virus. J Gen Virol 1996;77:1043-1054.
12. Shimizu YK, Iwamoto A, Hijikata M, Purcell RH, Yoshikura H. Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc Natl Acad Sci U S A 1992;89:5477-5481.
13. Mizutani T, Kato N, Saito S, Ikeda M, Sugiyama K, Shimotohno K. Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type 1-infected cell line, MT-2. J Virol 1996;70:7219-7223.
14. Mizuno M, Yamada G, Tanaka T, Shimotohno K, Takatani M, Tsuji T. Virion-like structures in HeLa cells transfected with the full-length sequence of the hepatitis C virus genome. Gastroenterology 1995;109: 1933-1940.
15. Yoo BJ, Selby MJ, Choe J, Suh BS, Choi SH, Joh JS, Nuovo GJ, et al. Transfection of a differentiated human hepatoma cell line (Huh7) with in vitro-transcribed hepatitis C virus (HCV) RNA and establishment of a long-term culture persistently infected with HCV J Virol 1995;69:32-38.
16. Harada S, Suzuki R, Ando A, Watanabe Y, Yagi S, Miyamura T, Saito I. Establishment of a cell line constitutively expressing E2 glycoprotein of hepatitis C virus and humoral response of hepatitis C patients to the expressed protein. J Gen Virol 1995;76:1223-1231.
17. Harada T, Kim DW, Sagawa K, Suzuki T, Takahashi K, Saito I, Matsuura Y, et al. Characterization of an established human hepatoma cell line constitutively expressing non-structural proteins of hepatitis C virus by transfection of viral CDNA. J Gen Virol 1995;76:1215-1221.
18. Sells M, Chen M-L, Acs G. Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A 1987;84:1005-1009.
19. Weiss L, Kekulé A, Jakubowski U, Būrgelt E, Hofschneider PH. The HBV-producing cell line HepG2-4A5: a new in vitro system for studying the regulation of HBV replication and for screening anti-hepatitis B virus drugs. Virology 1996;216:214-218.
20. Shih C-M, Lo SJ, Miyamura T, Chen S-Y, Lee Y-HW. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol 1993;67:5823-5832.
21. Kim DW, Suzuki R, Harada T, Saito I, Miyamura T. Trans-suppression of gene expression by hepatitis C viral core protein. Jpn J Med Sci Biol 1994:47:211-220.
22. Ray RB, Steele R, Meyer K, Ray R. Transcriptional repression of p53 promoter by hepatitis C virus core protein. J Biol Chem 1997;272:10983-10986.
23. Kato T, Ahmed M, Yamaraoto T, Takahashi H, Oohara M, Ikeda T, Aida Y, et al. Inactivation of hepatitis C virus cDNA transgene by hypermethylation in transgenic mice. Arch Virol 1996;141:951-958.
24. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 1992;89:5547-5551.
25. Moradpour D, Englert C, Wakita T, Wands JR. Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology 1996;222:51-63.
26. Grakoui A, Wychowski C, Lin C, Feinstone SM, Rice CM. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 1993;67:1385-1395.
27. Dubuisson J, Hsu HH, Cheung RC, Greenberg HB, Russell DG, Rice CM. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol 1994;68:6147-6160.
28. Englert C, Hou X, Maheswaran S, Bennett P, Ngwu C, Re GG, Garvin AJ, et al. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J 1995;14:4662-4675.
29. Morgenstern JP, Land H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 1990;18:3587-3596.
30. Chen C, Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 1987;7:2745-2752.
31. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. (2nd ed.) Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.